Analysts Set Verona Pharma plc (NASDAQ:VRNA) Price Target at $82.13
Verona Pharma plc (NASDAQ:VRNA – Get Free Report) has been assigned a consensus recommendation of “Buy” from the ten ratings firms that are covering the company, Marketbeat.com reports. Nine investment analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12 month price […]
Verona Pharma plc (NASDAQ:VRNA – Get Free Report) has been assigned a consensus recommendation of “Buy” from the ten ratings firms that are covering the company, Marketbeat.com reports. Nine investment analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12 month price […]
